Neglected burden of obstructive sleep apnoea: workplace productivity loss in the USA and UK.
No Thumbnail Available
Authors
Rehman U.
Ahn Y.
Yerushalmi E.
Abdelwahab M.
EynonLewis N.
Liu J.
Sutton L.
Holsinger F.C.
Capasso R.
Cote M.L.
Contact
Check for full-text access
Issue Date
2026
Type
Article
Language
Keywords
Alternative Title
Abstract
This study estimates the prevalence and workplace productivity burden of obstructive sleep apnoea (OSA) syndrome in the UK and USA, using self-reported breathing pauses and excessive daytime sleepiness as a proxy. The prevalence of OSA syndrome was 22.8% in the USA and 19.5% in the UK. Annual productivity losses were estimated at US$180.2 billion in the USA and 4.22 billion in the UK. In the UK and USA, individual-level productivity losses exceeded the cost of continuous positive airway pressure (CPAP) treatment, suggesting that improved identification, access to treatment and adherence could yield significant economic benefits in both countries. Copyright © Author(s) (or their employer(s)) 2026. No commercial re-use. See rights and permissions. Published by BMJ Group.
Description
Citation
Publisher
License
Journal
Thorax